Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Roche 17.5245, AstraZeneca 15.384.
* Roche reports semi-annually. Values are evenly split across both quarters within each half.
Roche vs AstraZeneca: Revenue Comparison
Roche (RHHBY) and AstraZeneca (AZN) are peers in GLP-1. Roche reported revenue of $35.0B as of Q2 2026, compared with $15.4B for AstraZeneca. Roche leads on revenue.
Roche's gross margin is 73.7% versus 83.6% for AstraZeneca. Roche's net margin is 22.6% versus 16.3% for AstraZeneca.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Roche, AstraZeneca.| Metric | Roche | AstraZeneca |
|---|---|---|
| Market Cap | - | - |
| Revenue | $35.05B | $15.38B |
| Cost of Revenue | $9.21B | $2.52B |
| Gross Profit | $25.84B | $12.86B |
| Operating Income | $10.90B | $3.16B |
| Net Income | $7.93B | $2.51B |
| R&D Expense | $8.35B | $4.05B |
| Earnings Per Share | $1.23 | $1.59 |
| Gross Margin | 73.7% | 83.6% |
| Operating Margin | 31.1% | 20.6% |
| Net Profit Margin | 22.6% | 16.3% |
| Free Cash Flow | $6.46B | $2.13B |
| Cumulative Free Cash Flow | $305.80B | $121.22B |
| Operating Cash Flow | $8.28B | $2.89B |
| Cash & Equivalents | $6.13B | $4.89B |